Author: CDPC

  • Coalition Spotlight: Canadian HIV/AIDS Legal Network

    Coalition Spotlight: Canadian HIV/AIDS Legal Network

    The HIV epidemic is one of the most crucial public health issues of our time. What at one time seemed to be an insurmountable challenge has been abetted by education, research, innovation, and an immeasurable amount of hard work. The tools to curb the spread of HIV and improve the lives and health of those living with the disease are now more widely available, but the possibility of fostering an AIDS-free generation still faces a number of obstacles, most of which relate to unrealized human rights, access to medicine, harm reduction, and unjust laws.

    One of most prolific groups working on solving the problems that are currently hindering the fight against HIV/AIDS is the Toronto-based Canadian HIV/AIDS Legal Network. Celebrating its 20th year of operations this December, the Canadian HIV/AIDS Legal Network is Canada’s leading advocacy organization dedicated to legal and human rights issues related to HIV/AIDS. The network’s mission is to promote the human rights of those living with and vulnerable to HIV/AIDS, in Canada and abroad, through research and analysis, advocacy and litigation, public education and community mobilization.

    One such issue that the Legal Network is currently working on is the matter of syringe exchanges in Canadian prisons. Syringe exchange is critical to any comprehensive strategy to prevent the spread of infectious diseases, but the distribution of sterile injection equipment is not currently permitted within any Canadian prison — despite the overwhelming evidence of the benefits of prison-based needle and syringe programs (PNSPs) around the world

    To challenge this policy, the Canadian HIV/AIDS Legal Network, along with Prisoners with HIV/AIDS Support Action Network (PASAN), CATIE, the Canadian Aboriginal AIDS Network (CAAN) and Steven Simons, a former federal prisoner, launched a lawsuit on September 25th against the Government of Canada over “its failure to protect the health of people in prison through its ongoing refusal to implement clean needle and syringe programs to prevent the spread of HIV and hepatitis C virus (HCV) in federal institutions.”

    Rates of HIV and hepatitis C among Canadian prisoners are 10 to 30 times higher to that of the overall population. Although illicit drug use is strictly prohibited within correctional facilities, its prevalence is an undeniable fact.

    While the question of giving prisoners access to clean injection equipment might at first glance seem counterintuitive, it’s actually quite straightforward given the evidence that PNSPs benefit prisoner health, and in turn, the public health at large.

    For more information on the court case and PNSPs, visit the Canadian HIV/AIDS Legal Network’s website for the campaign – Prison Health Now.

    In addition to matters directly related to drug policy such as PNSPs, the Canadian HIV/AIDS Legal Network deals with issues such as discrimination, Aboriginal communities, women’s rights, sex work, income security, and so forth (click here for a complete list).

    Other current campaigns and activities include:

    Positive Women: Exposing Injustice

    A 45-minute documentary film that tells the personal stories of four HIV-positive women, “Positive Women Exposing Justice” explores the reality of the criminalization of HIV non-disclosure in Canada. For more information, visit the film’s website.

    HIV Non-Disclosure and the Criminal Law

    On October 25th, the Legal Network released several publications analyzing two recent Supreme Court rulings on cases of HIV non-disclosure. A summary of the decisions and a longer analysis are available here.

    Making Good on Canada’s Pledge: Affordable Medicines for All

    For many years, the Legal Network has spearheaded a global campaign to reform Canada’s Access to Medicine Regime (CAMR), which would allow Canada to ensure greater access to affordable, generic medicines for AIDS and other health issues in developing countries. Central to this campaign is Bill C-398, which if passed will fix and streamline CAMR, allowing medications to get to those most in need.

    For more information on Bill C-398, visit the Canadian HIV/AIDS Legal Network Medicines for All website.

    On December 4, 2012, at 7:00 p.m., philanthropists, funders, members, community organizations, people living with HIV/AIDS, and allies will gather at the Law Society of Upper Canada (Convocation Hall) in Toronto to celebrate the Canadian HIV/AIDS Legal Network and honour the recipients of the 2012 Awards for Action on HIV/AIDS and Human Rights. Click here for more information on the event.

    The Canadian HIV/AIDS Legal Network is a Canadian Drug Policy Coalition partner in change, working towards a better drug policy for Canada based on evidence, human rights, social inclusion and public health.

  • Drug Policy 101: Dangers of an Unregulated Drug Market

    Drug Policy 101: Dangers of an Unregulated Drug Market

    “We need to recognize that it’s not deviant or pathological for humans to desire to alter their consciousness with psychoactive substances. They’ve been doing it since pre-history… and it can be in a religious context, it can be in a social context, or it can be in the context of symptom management.”

    Dr. Perry Kendall, Provincial Health Officer, British Columbia

    If the past century of prohibition has proved anything, it is that the Controlled Drugs and Substances Act has failed to discourage Canadians from using illegal drugs. Likewise, prohibition has also shown us that the financial incentive to produce and sell illegal drugs is far more powerful than the deterrent effect of the criminal law.

    This ongoing flow of supply and demand has, of course, resulted in a large and highly profitable black market for drugs in Canada. One aspect of this black market that goes unaddressed by the criminal justice system is that prohibition results in a situation where Canadians are consuming a completely unregulated product.

    Because the product is unregulated, its quality is not just questionable, but potentially dangerous. And those individuals who use drugs of questionable quality often have no idea as to the nature of the substance they are consuming.

    Some of the most illuminating examples of the dangers of an unregulated market can be found in relation to the differences between “ecstasy” and MDMA. In its pure form, and taken in controlled doses, MDMA is a relatively safe substance when compared to other drugs, legal and illegal.

    Many scientists and doctors have argued in favour of its regulation, including former UK government drugs advisor David Nutt, who recently conducted a televised study of MDMA’s therapeutic potential, and BC Provincial Health Officer Dr. Perry Kendall, who went on the record stating that MDMA could be “safe” for adults if consumed responsibly, and has called for a public dialogue on a regulatory regime. Such a dialogue could enable a full and honest discussion on the benefits and harms of using substances such as MDMA and similar drugs.

    But because MDMA isn’t currently regulated by a governing body, we have “ecstasy” which is regulated by the criminal element that currently controls its distribution. “Ecstasy” as opposed to pure MDMA, can contain a combination of various drugs, such as PCP, ketamine, methamphetamines and others. This leads to unknown purity, unknown dosage and the possibility that a pill could be contaminated. And the results of consuming pills of unknown origin can be tragic. Examples of the dangers of the current ecstasy market include a string of deaths throughout western Canada, where individuals using ecstasy died because the pills they took were cut with PMMA; a stimulant that has been linked to a number of deaths around the world during the same timeframe.

    These and similar deaths have lead many communities around the country to call for a different approach to how we deal with drugs like ecstasy, as “Just Say No” programs and wishing abstinence upon young people is clearly not working.

    Next Steps:

    As the current approach, which relies upon fear and ignorance to dissuade Canadians from using MDMA has failed, Canada should adopt a knowledge-based approach to best ensure that those who use MDMA and other drugs stay safe and informed.

    One of such existing approaches is the Dutch Drugs and Information Monitoring System (DIMS); a country-wide system of labs that will analyze substances without any threat of legal recourse. Since the 1990s, the Netherlands government has used this system as a measure to prevent the harms associated with unexpected and dangerous substances found in “party pills” and other drugs. The three main substances that DIMS tests are ecstasy/MDMA, amphetamine/Speed, and cocaine, and has tested some 100,000 drug samples since being established. Implementing such a system in Canada would have numerous public health benefits, including allowing drug users to have a full understanding of what they are actually taking, while also enabling public health authorities to respond more effectively when hazardous substances appear on the drug market.

    Long term solution: A regulated drug market

    MDMA is subject to the UN convention on psychotropic substances, rendering it illegal around the world, and any country that attempted to regulate it would be in violation of this treaty. However, there is currently legislation in front of the New Zealand government that would see the creation of the world’s first regulated recreational drug market.

    Under the new regulations, synthetic drugs, also known as “legal highs” or “party pills” would have to undergo an approval process before being brought to market. This process would place the burden on the synthetic drug industry, which would have to prove its products are safe before being made available to the consumer. Taking up to two years, the approval process will determine the effects and side-effects of a proposed drug, measuring it against an established health criteria.

    While it will only cover new drugs, i.e. those not covered by existing UN treaties, New Zealand’s proposed system could function as a blueprint for other nations to pursue the regulation of recreational drugs in the future.

  • Book Review-The Political Economy of Narcotics: Production, Consumption and Global Markets

    Book Review-The Political Economy of Narcotics: Production, Consumption and Global Markets

    001d3d57_mediumby Craig Jones Former Executive Director, The John Howard Society of Canada.

    The Political Economy of Narcotics: Production, Consumption and Global Markets
    By Julia Buxton, PhD
    Zed Books, 2007,

    Julia Buxton sets herself two purposes: first, to explain how the “balloon effect” undermines even the best executed drug prohibition policies conceived according to the logic of supply suppression and, second, to lay the blame for all the evils associated with global drug prohibition at the feet of the United States. In both purposes she succeeds through the mobilization of abundant evidence – for the first purpose – and historical argument for the second.

    The book is organized into sixteen chapters starting with the history of intoxicating substances and ending with a short but pointed review of how the global prohibitionist regime has deprived humanity of one of nature’s most flexible and useful products: hemp. Throughout, Buxton weaves historical narrative into a discussion of the political interests and personalities which shaped the ideology of supply suppression that came to be embodied in the institutions of international drug control through the United Nations Conventions. Missing from this account, however, is the public choice story of how specific institutions in the United States captured the drug control issue and turned it to the growth of their own mission, organizational ambit and resource base.

    Though not unique to the United States, the political economy of American politics – particularly the outsized influence of specific individuals occupying particular offices – has given, and continues to give, the United States extraordinary influence over United Nations drug control conventions. Effectively, the United States has – with the compliance of most of the world’s major states – exported its own supply-side drug suppression preference to the rest of the planet through its control over the relevant United Nations institutions. This has resulted in these organs gaining extraordinary influence over the application of the drug conventions in member countries with the effect of limiting the range of the possible where harm reduction and non-prohibitionist alternatives are concerned. This, Buxton argues, has been a catastrophe – and not just for drug users.

    For it is the irrefutable truth that drug prohibition cuts across and poisons every policy domain associated with the modern nation state. There is almost no issue area – as Buxton shows in chapter after chapter – that is not complicated or made more problematic by the aggressive criminality that supply-side drug prohibition unleashes. Nor does it have to be this way. But for the singular obsessive policy focus of American prohibitionists, much could have been done to address demand – and the harm that arises from demand – with considerable benefits for public health and the reduction of crime. Like others who have examined this issue, Buxton finds that drug prohibition, American-style, amounts to harm maximization.

    Of the evils associated with global drug prohibition, she is nearly exhaustive – at least in itemizing the worst of them. A longer book could have gone into more detail on the pervasive corruption of authorities in countries which most vigorously enforce prohibition. Much of what is wrong with drug prohibition is explained at a high, though not too high, level of abstraction – and well referenced in the bibliography – making this a good choice for a university or college course on the harm and unintended consequences global drug prohibition.

    Buxton spares no criticism for the mechanisms and methodologies of data collection employed by the international regimes responsible for prosecuting the global drug war. Anyone following this issue has already concluded that even the most reliable numbers and data leave much to be desired. From one annual UN World Drug Report to another the metrics change, trends are dropped or initiated and the reader comes away wondering whether there is a systematic effort to enable or inhibit critical scrutiny of what’s really going on. This, Buxton explains, arises from a preference for quantitative methodologies while ignoring qualitative data, methods and approaches that would create a more fleshed-out perspective of drugs and drug users.

    Buxton is not the first, and won’t be the last, to argue that drug prohibition has been aided and abetted by the kind of science that is funded in its name. This too is an area that might have warranted deeper explanation. The political economy of research funding on drugs and their effects – much of it funded through the U.S. National Institutes of Health — is heavily skewed toward the production of negative findings, a feature of how the institutions which fund research into illicit drugs have been captured by the ideology and interests of supply-side strategies.

    Students of drug prohibition have studied to the “balloon effect” since the debut of the war on drugs in the Nixon Administration. The phenomenon is easy to understand. Using a drug control strategy premised upon supply suppression – as distinct from demand reduction – initiates a pattern whereby eradication in one region produces a surge of production in another, much the way squeezing a balloon in one place causes it to expand elsewhere. This iterative model has been observed countless times, yet ideology and organizational interests combine to disable prohibitionists from learning any lesson except to do more of the same.

    The second feature of the balloon effect that Buxton touches on, but not does fully develop, is the widely observed tendency for a process of natural selection to take hold with drug traffickers and suppliers. This takes the form of state authorities weeding out the week and inefficient trafficking networks through crackdown in one region which produces the unintended consequence of strengthening the survivors and reducing their competition. Drug prohibition, seen in this light, is a strategy for driving drug traffickers and producers toward more violent tactics and practices – such as we are currently seeing on the Mexico-United States border. Only the most innovative and ruthless producers survive, pushing the global drug war into a spiral of increasingly militarized violence as traffickers adopt the tactics and weapons of national armies with whom they are increasingly in direct combat.

    For students of drug prohibition, there is little that is new here. Buxton puts the arguments together with good effect, showing how the execution of supply-side focused drug prohibition makes everything about drugs, and drug use, worse than it would otherwise be. My only quarrel is that she could have been more explicit in drawing out the political economy implications of her arguments for readers who ask “What’s this got to do with me?” Buxton could have been more explicit in showing how the crusading pursuit of an unachievable utopia bends the energies and resources of the state, and its enforcement apparatus, to undemocratic and militaristic ends while enriching and enlarging the power and violence of organized crime. We all have a dog in this fight. We are all collateral damage in the war on drugs.

    Craig Jones, PhD
    Kingston ON

  • Sir Richard Branson: ‘Time to end the war on drugs’

    Sir Richard Branson: ‘Time to end the war on drugs’

    Ten years ago the Portuguese Government responded to widespread public concern over drugs by rejecting a “war on drugs” approach and instead decriminalized drug possession and use. It further rebuffed convention by placing the responsibility for decreasing drug demand as well as managing dependency under the Ministry of Health rather than the Ministry of Justice. With this, the official response towards drug-dependent persons shifted from viewing them as criminals to treating them as patients.

    Now with a decade of experience Portugal provides a valuable case study of how decriminalization coupled with evidence-based strategies can reduce drug consumption, dependence, recidivism and HIV infection and create safer communities for all.

    I will set out clearly what I learned from my visit to Portugal and would urge other countries to study this:

    In 2001 Portugal became the first European country to officially abolish all criminal penalties for personal possession of drugs, including marijuana, cocaine, heroin and methamphetamines.

    Jail time was replaced with offer of therapy. (The argument was that the fear of prison drives addicts underground and that incarceration is much more expensive than treatment).

    Under Portugal’s new regime, people found guilty of possessing small amounts of drugs are sent to a panel consisting of a psychologist, social worker, and legal adviser for appropriate treatment (which may be refused without criminal punishment), instead of jail.

    Critics in the poor, socially conservative and largely Catholic nation said decriminalizing drug possession would open the country to “drug tourists” and exacerbate Portugal’s drug problem; the country has some of the highest levels of hard-drug use in Europe. The recently realised results of a report commissioned by the Cato Institute, suggest otherwise.

    The paper, published by Cato in April 2011, found that in the five years after personal possession was decriminalized, illegal drug use among teens in Portugal declined and rates of new HIV infections caused by sharing of dirty needles dropped, while the number of people seeking treatment for drug addiction more than doubled.

    It has enabled the Portuguese government to manage and control the problem far better than virtually every other Western country does.

    Compared to the European Union and the US, Portugal drug use numbers are impressive.

    Following decriminalization, Portugal has the lowest rate of lifetime marijuana use in people over 15 in the EU: 10%. The most comparable figure in America is in people over 12: 39.8%, Proportionally, more Americans have used cocaine than Portuguese have used marijuana.

    The Cato paper reports that between 2001 and 2006 in Portugal, rates of lifetime use of any illegal drug among seventh through ninth graders fell from 14.1% to 10.6%. Drug use in older teens also declined. Life time heroin use among 16-18 year olds fell from 2.5% to 1.8%.

    New HIV infections in drug users fell by 17% between 1999 and 2003.

    Death related to heroin and similar drugs were cut by more than half.

    The number of people on methadone and buprenorphine treatment for drug addiction rose to 14,877 from 6,040, after decriminalization, and the considerable money saved on enforcement allowed for increase funding of drug – free treatment as well.

    Property theft has dropped dramatically (50% – 80% of all property theft worldwide is caused by drug users).

    America has the highest rates of cocaine and marijuana use in the world, and while most of the EU (including Holland) has more liberal drug laws than the US, it also has less drug use.

    Current policy debate is that it’s based on “speculation and fear mongering”, rather than empirical evidence on the effect of more lenient drug policies. In Portugal, the effect was to neutralize what had become the country’s number one public health problem.

    Decriminalization does not result in increased drug use.

    Portugal’s 10 year experiment shows clearly that enough is enough. It is time to end the war on drugs worldwide. We must stop criminalising drug users. Health and treatment should be offered to drug users – not prison. Bad drugs policies affect literally hundreds of thousands of individuals and communities across the world. We need to provide medical help to those that have problematic use – not criminal retribution.

    READ THIS POST ON RICHARD”S BLOG >>

    For more info on Drug Policy in Portugal, take a look at the report issued by the Open Society Institute last August.
    Drug Policy in Portugal: The Benefits of Decriminalizing Drug Use >>

  • Count the Cost Report: The War on Drugs: Creating crime, enriching criminals

    Count the Cost Report: The War on Drugs: Creating crime, enriching criminals

    Far from eliminating drug use and the illicit trade, prohibition has inadvertently fuelled the development of the world’s largest illegal commodities market – a market worth hundreds of billions of dollars, controlled solely by criminal profiteers. Produced in collaboration with project supporters Law Enforcement Against ProhibitionTransform Drug Policy FoundationRelease, theInternational Centre for Science in Drug Policy and Harm Reduction International, the latest Count the Costs briefing outlines how this illicit, unregulated market generates:

    • Street crime
    • Mass incarceration
    • Violent crime
    • Crimes perpetrated by governments/states
    • Vast economic costs in terms of drug war-related enforcement

    The briefing will form a key part of our outreach to mainstream NGOs working in the criminal justice sector, building on the endorsements Count the Costs has already received from organisations such as the Howard League for Penal Reform and Make Justice Work.

    Evidence from across the world reveals that although law enforcement can show seemingly impressive results in terms of arrests and seizures, impacts on the drug market are inevitably marginal, localised and temporary. Indeed, as the United Nations Office on Drugs and Crime acknowledges, one of the unintended consequences of the war on drugs is the so-called “balloon effect”, whereby rather than eliminating criminal activity, enforcement just moves it somewhere else. When enforcement does take out criminals, it also creates a vacuum, and even more violence, as rival gangs fight for control.

    The Count the Costs initiative has the widely shared goal of a safer, healthier and more just world. It is time for all sectors affected by current approaches to drugs, particularly those agencies, organisations and individuals concerned with crime reduction, to call on governments and the UN to Count the Costs of the war on drugs and explore the alternatives.

    Read more at Count the Cost >>

  • Book Review – A Plague of Prisons: The Epidemiology of Mass Incarceration in America

    Book Review – A Plague of Prisons: The Epidemiology of Mass Incarceration in America

    Druckerby Craig Jones Former Executive Director, The John Howard Society of Canada.

    A Plague of Prisons: The Epidemiology of Mass Incarceration in America
    By Ernest Drucker
    The New Press, 2011, pp. xiv, 211

    Every student of epidemiology learns the story of the Broad Street pump (London, Summer 1854), which marks the birth of epidemiology. In A Plague of Prisons, Ernest Drucker uses that story as a metaphor to explain the explosion of incarceration in the United States that followed the 1973 enactment of the Rockefeller drug laws and to illustrate how political decisions act as vectors – pumps – and how these vectors create a social epidemic of gargantuan proportions. Drucker is professor emeritus of family and social medicine at Montefiore Medical Center/Albert Einstein College of Medicine. He was present at the creation of the AIDS epidemic in the Bronx in the early 1980s and watched how politics, ignorance, homophobia and racism facilitated the transmission of disease from certain neighborhoods and populations to a much larger population via the Riker’s Island prison.Between 1880 and roughly 1975, American rates of incarceration were stable at roughly 75 per 100,000 population. Today that number hovers around 743 per 100,000. Drucker’s project is to explain the political path between those two numbers. Drucker employs epidemiology to explain the mechanism by which the United States came to incarcerate 1 out of every 4 incarcerated persons in the world. He can be read in three ways: as an undergraduate introduction to the explanatory power of social epidemiology; as a non-technical analysis of how the United States achieved its historically unprecedented rate of incarceration; and as a warning to Canadians on the propensity of criminalization of non-violent drug users to become a contagion with multi-generational consequences. The book’s timing is apt: Canadians are enacting the political mistakes that produced the plague of prisons in the United States.What were those mistakes? There were three elements embedded in the Rockefeller drug laws that transformed a public health issue into mass incarceration and transmitted that contagion to the entire country. In chronological sequence they are: the decision to criminalize drug use; the political reliance on punishment as the appropriate response; and, the attack on judicial discretion through mandatory minimum sentences. Of the three, the criminalization of drug use featuring large-scale arrests of low-level drug users primed the pump that fueled the contagion of self-sustaining criminality.There are important differences in the way criminal justice is done between the United States and Canada – some of those differences will insulate Canada from the worst effects of the plague of prisons. But there are a couple of lessons for Canadians too. The first is that criminal justice policy is too often made in a consequentialist vacuum – that is, without deliberation over downstream effects on families and particularly children of the incarcerated who will likely be the next generation of the incarcerated. The political imperatives that pushed US policy makers into adopting mandatory minimum sentences appealed to the short-term interests of private prison contractors, correctional officer unions, victims’ advocates, judges and prosecutors. Policies enacted for short-term political opportunity have long-term economic and social consequences, a long tail, but these are of little moment compared to the immediate electoral advantage. The children of the incarcerated – who are at higher risk of incarceration themselves – have no one to speak for them, at least no one with the clout of correctional officer unions or private prison contractors.

    The second lesson is that it is hard to reverse bad policy ideas once they take hold in the public imagination – even once the fiscal costs become unsustainable and the policy itself is clearly failing. As is now clear, the proliferation of mandatory sentencing regimes across the United States has pushed several jurisdictions – Texas, California, Ohio, Florida and New York – to the brink of insolvency, yet they have not achieved rates of crime reduction greater than those jurisdictions that did not embrace draconian sentencing practices. Worse, the sentencing regimes are hard to unwind because they have created a political constituency where prisons have become a source of high-income, non-polluting jobs. The third lesson Canadians should heed is that – in seeking to increase the burden of punishment – criminal justice systems engender a self-perpetuating underclass of non-violent but ever more marginalized persons who, because of onerous pardon requirements, may never be reintegrated. They simply cycle through the prison system and transmit the contagion of criminality to their children and family members.

    This is a cautionary tale. Canadians would be wise to be more attentive to Drucker’s warnings on the self-sustaining dynamic that emerges out of deliberately growing the rate of incarceration for electoral advantage.

    Craig Jones, PhD
    Former Executive Director
    The John Howard Society of Canada
    Kingston  ON

  • B.C. physicians issue report on drug policy and law reform

    B.C. physicians issue report on drug policy and law reform

    Tuesday, November 29, 2011 by David Eby (Reposted with permission)

    It’s hard to imagine an area more difficult for politicians talk about than drug policy reform.

    Maybe raising taxes.

    BC-Health-Officers-ReportToday, B.C.’s Health Officers council gave the politicians some breathing room by issuing a report that calls for a provincial dialogue on reforming drug law in Canada and B.C. Not exactly a group of flaming radicals, the Health Officers Council is the professional association of public health physicians in B.C. They issue reports on the health impacts of, for example, driving while using your cell phone.

    Ten years ago, few people could have imagined a functioning facility where nurses would supervise addicts injecting heroin, morphine and cocaine to make sure they didn’t kill themselves in the process; that it would be supported by the health authority, municipal government and provincial government.

    Similarly, ten years ago, few people could have imagined a study that looks at the outcome of prescribing heroin and hydromorphone to people who have failed at drug treatment. There has been one already. The second study is underway. Both in British Columbia. Both in Vancouver.

    Today the majority of Canadians support Insite. British Columbians support drug policy reform that makes us safer and healthier, and have linked our endemic gang violence to the drug trade. But that hasn’t been enough so far to open the door to even a discussion of reform and decriminalizing drug addicts. If anything, our drug law is going the other way, with tougher penalties and more jail time for addicts, despite the American experience.

    There is now a little more space for those in positions of power to take up the Health Officers’ call for a public discussion about what’s working, and what’s not working, in our current drug policy. Just a discussion. Hopefully, in ten years, we’ll look back and shake our heads at the inability of our society to even discuss how we could improve our drug policy’s effectiveness to increase safety, reduce harm, and reduce costs. Talk about reefer madness.

  • Canadian Drug Policy Coalition/ Doalition canadienne des politiques sur les drogues

    Thrown Under the Omnibus

    The idea for the Toronto forum on Bill C10 (the Safe Streets & Communities Act) – “Thrown Under the Omnibus” – was hatched at the harm reduction conference in Ottawa this past summer, during a round-table session that wrapped up the final day. Representatives of five Toronto-based organisations were present – The Toronto Harm Reduction Task Force, The Social Justice committee of the Community Justice Coalition, The Canadian HIV/AIDS Legal Network, PASAN and The Canadian Harm Reduction Network, as well as Donald MacPherson from the Canadian Drug Policy Coalition. It was decided that we would jointly host a forum on Bill C10 in Toronto, as one of a number of community events across Canada supported by the Coalition.

    Back in Toronto, we struck a planning committee culled from the five organisations. The committee also included a current drug user, a person on methadone, a former prisoner, and a very valuable volunteer who because of her employment found it prudent to remain anonymous. Such is life now in the big smoke!

    The Forum itself was very well attended. With an audience of about 225 people almost every seat was filled. It was well moderated and stimulating, and audience questions were addressed with thoroughness and respect.

    There was an excellent networking social after the Forum. We picked up a large number of addresses for our growing mailing list. We had a positive article in the National Post. We also saw many new faces. We had made a particular effort to expand our reach to people outside our usual social services, prison activist and policy lists … particularly into the arts communities, for example … and a number of them turned up.

    What would I do differently the next time?

    Ensure that there is a next time. We need to build on interest and success. Put greater concentration on expanding the audience base. We need to “convert” even more than we need to speak to the converted. We need to form new relationships and coalitions as well as nurturing existing ones.

    Do more with social media. We did some … but none of us was particularly savvy.Really court the media. We did a lot … but obviously we need to do more. Hold a post mortem. We never did it. Perhaps we still will.

    Really celebrate our success.